MAY 28, 2015
Urge Your Representative to Sign Letter to FDA to Preserve Access to Repackaged Avastin
The Academy is urging its members to reach out to their representatives to encourage them to join a letter to the Food and Drug Administration regarding access to repackaged biologics, including bevacizumab.